Venlafaxine Hydrochloride Capsules

This product mainly exerts its antidepressant effect by inhibiting the reuptake of serotonin and norepinephrine by the central nervous system, thereby increasing the concentration of these two monoamine transmitters in the synaptic cleft.

The main ingredient of this product is venlafaxine hydrochloride. Chemical name: (±)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol hydrochloride.

This product is a capsule, and the contents are white powder.

This product is suitable for various types of depression, including depression accompanied by anxiety and generalized anxiety disorder.

Oral administration: The initial dose is 25 mg once, 2 to 3 times a day, and gradually increase to 75 mg to 225 mg per day, divided into 2 to 3 times. The maximum dose is 350 mg per day. It can be taken with food. Or follow the doctor's advice.

Gastrointestinal discomfort such as nausea, anorexia, diarrhea, etc. may occur. Headache, restlessness, weakness, drowsiness, insomnia, dizziness or tremor may also occur. Rare adverse reactions include allergic rash and sexual dysfunction. It can cause high blood pressure, which is positively correlated with the dose. High doses can induce epilepsy. Sudden discontinuation of the drug may cause withdrawal syndrome such as insomnia, anxiety, nausea, sweating, tremor, dizziness or paresthesia.

It is contraindicated for patients who are allergic to this product or those who are taking monoamine oxidase inhibitors.

1 When used in combination with selective serotonin reuptake inhibitors or monoamine oxidase inhibitors, it may cause hypertension, rigidity, myoclonus, involuntary movements, anxiety, impaired consciousness and even coma and death. Therefore, when switching from one drug to another, a wash-out period of 7 to 14 days is required. 2 When used in combination with quinidine, the blood concentration of this product may increase. 3 When used in combination with beta-blockers propranolol, metoprolol, timolol or with tricyclic antidepressants amitriptyline, clomipramine, imipramine or with antiarrhythmic drugs propafenone, codeine and dextromethorphan, it may competitively inhibit the metabolism of this product. 4 When used in combination with cimetidine, this product may clear

Seal and store in a dry place. Valid for 36 months

12.5mg

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

• Founded in:

  1996-10-03

• Address:

  No. 108, Shuxi Road, Jinniu District, Chengdu, Sichuan

• Tax NO.:

  91510100633116839D

• Registered Funds:

  919.463954 million yuan

• Website:

  Log in to view

• Email:

  Log in to view